APA (7th ed.) Citation

Paolini, E., Longo, M., Meroni, M., Tria, G., Cespiati, A., Lombardi, R., . . . Dongiovanni, P. (2023). The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value. Frontiers in nutrition (Lausanne), 10, 1101341. https://doi.org/10.3389/fnut.2023.1101341

Chicago Style (17th ed.) Citation

Paolini, Erika, et al. "The I148M PNPLA3 Variant Mitigates Niacin Beneficial Effects: How the Genetic Screening in Non-alcoholic Fatty Liver Disease Patients Gains Value." Frontiers in Nutrition (Lausanne) 10 (2023): 1101341. https://doi.org/10.3389/fnut.2023.1101341.

MLA (9th ed.) Citation

Paolini, Erika, et al. "The I148M PNPLA3 Variant Mitigates Niacin Beneficial Effects: How the Genetic Screening in Non-alcoholic Fatty Liver Disease Patients Gains Value." Frontiers in Nutrition (Lausanne), vol. 10, 2023, p. 1101341, https://doi.org/10.3389/fnut.2023.1101341.